PMID- 37278873 OWN - NLM STAT- MEDLINE DCOM- 20230608 LR - 20230922 IS - 1438-7948 (Electronic) IS - 1438-793X (Print) IS - 1438-793X (Linking) VI - 23 IP - 3 DP - 2023 Jun 6 TI - Exploration of the potential common pathogenic mechanisms in COVID-19 and silicosis by using bioinformatics and system biology. PG - 199 LID - 10.1007/s10142-023-01092-2 [doi] LID - 199 AB - Silicosis is an occupational lung disease that is common worldwide. In recent years, coronavirus disease 2019 (COVID-19) has provided daunting challenges to public healthcare systems globally. Although multiple studies have shown a close link between COVID-19 and other respiratory diseases, the inter-relational mechanisms between COVID-19 and silicosis remain unclear. This study aimed to explore the shared molecular mechanisms and drug targets of COVID-19 and silicosis. Gene expression profiling identified four modules that were most closely associated with both diseases. Furthermore, we performed functional analysis and constructed a protein-protein interaction network. Seven hub genes (budding uninhibited by benzimidazoles 1 [BUB1], protein regulator of cytokinesis 1 [PRC1], kinesin family member C1 [KIFC1], ribonucleotide reductase regulatory subunit M2 [RRM2], cyclin-dependent kinase inhibitor 3 [CDKN3], Cyclin B2 [CCNB2], and minichromosome maintenance complex component 6 [MCM6]) were involved in the interaction between COVID-19 and silicosis. We investigated how diverse microRNAs and transcription factors regulate these seven genes. Subsequently, the correlation between the hub genes and infiltrating immune cells was explored. Further in-depth analyses were performed based on single-cell transcriptomic data from COVID-19, and the expression of hub-shared genes was characterized and located in multiple cell clusters. Finally, molecular docking results reveal small molecular compounds that may improve COVID-19 and silicosis. The current study reveals the common pathogenesis of COVID-19 and silicosis, which may provide a novel reference for further research. CI - (c) 2023. Fondazione Societa Italiana di Neurologia. FAU - Tian, Yunze AU - Tian Y AD - Department of Thoracic Surgery, the Second Affiliated Hospital of Xi'an Jiao Tong University, Shaanxi Province, Xi'an, 710004, China. AD - Department of Neurosurgery, the Second Affiliated Hospital of Xi'an Jiao Tong University, Shaanxi Province, Xi'an, 710004, China. FAU - Yu, Beibei AU - Yu B AD - Department of Neurosurgery, the Second Affiliated Hospital of Xi'an Jiao Tong University, Shaanxi Province, Xi'an, 710004, China. FAU - Zhang, Yongfeng AU - Zhang Y AD - Department of Neurosurgery, the Second Affiliated Hospital of Xi'an Jiao Tong University, Shaanxi Province, Xi'an, 710004, China. FAU - Zhang, Sanpeng AU - Zhang S AD - Operating room, the Second Affiliated Hospital of Xi'an Jiao Tong University, Shaanxi Province, 710004, Xi'an, China. FAU - Lv, Boqiang AU - Lv B AD - Department of Neurosurgery, the Second Affiliated Hospital of Xi'an Jiao Tong University, Shaanxi Province, Xi'an, 710004, China. FAU - Gong, Shouping AU - Gong S AD - Department of Neurosurgery, the Second Affiliated Hospital of Xi'an Jiao Tong University, Shaanxi Province, Xi'an, 710004, China. shpingg@126.com. FAU - Li, Jianzhong AU - Li J AD - Department of Thoracic Surgery, the Second Affiliated Hospital of Xi'an Jiao Tong University, Shaanxi Province, Xi'an, 710004, China. jianzhong-0520@163.com. LA - eng GR - 81903268/National Natural Science Foundation of China/ PT - Journal Article DEP - 20230606 PL - Germany TA - Funct Integr Genomics JT - Functional & integrative genomics JID - 100939343 SB - IM EIN - Funct Integr Genomics. 2023 Jul 14;23(3):240. PMID: 37442826 MH - Humans MH - *COVID-19/genetics MH - Molecular Docking Simulation MH - Protein Interaction Maps/genetics MH - Computational Biology/methods MH - Gene Expression Profiling MH - *Silicosis/genetics PMC - PMC10241611 OTO - NOTNLM OT - COVID-19 OT - ScRNA-seq OT - Silicosis OT - Weighted correlation network analysis COIS- The authors declare no competing interests. EDAT- 2023/06/06 13:09 MHDA- 2023/06/08 06:42 PMCR- 2023/06/06 CRDT- 2023/06/06 11:08 PHST- 2023/01/11 00:00 [received] PHST- 2023/05/09 00:00 [accepted] PHST- 2023/05/07 00:00 [revised] PHST- 2023/06/08 06:42 [medline] PHST- 2023/06/06 13:09 [pubmed] PHST- 2023/06/06 11:08 [entrez] PHST- 2023/06/06 00:00 [pmc-release] AID - 10.1007/s10142-023-01092-2 [pii] AID - 1092 [pii] AID - 10.1007/s10142-023-01092-2 [doi] PST - epublish SO - Funct Integr Genomics. 2023 Jun 6;23(3):199. doi: 10.1007/s10142-023-01092-2.